Sweetch

Company Overview

Snapshot

Founded in October 2013 by Yossi Bahagon and Keren Shavit, Sweetch operates with 51–200 employees. The company has raised $44.8M across 8 funding rounds from 15 investors.

Business overview

Sweetch is a Health Tech & Life Sciences company that leverages AI and behavioral science to create hyper-personalized patient engagement platforms. Its core technology utilizes data from smartphones and connected devices to provide real-time, adaptive recommendations for managing chronic conditions. The company's proprietary Just-in-Time-Adaptive-Intervention (JITAI) technology continuously analyzes patient context and behavior to deliver tailored interactions, aiming to improve clinical outcomes and user engagement. Sweetch operates within the digital healthcare sector, focusing on patient engagement, and serves markets in Europe, the United States, South America, and Canada.

Strategic signal

This investment suggests a strategic validation of Sweetch's technology and its potential for further market expansion and product development in the health tech sector.

Company Intelligence Q&A

What is Sweetch's primary focus?

Sweetch focuses on empowering patients to manage chronic conditions through an AI-powered, hyper-personalized patient engagement platform that merges AI with behavioral science.

What was a significant partnership for Sweetch in 2021?

In September 2021, Sweetch entered a strategic partnership with Grupo Fleury's Saúde iD to address chronic disease prevalence in Brazil.

What was the focus of Sweetch's product update in October 2022?

In October 2022, Sweetch launched Sweetch 2.0, which was designed to revolutionize patient partnership in managing chronic disease.